Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for life ...
read more
Tuesday, September 17, 2019
PHASTAR will establish a U.S. west coast office in California.
read more
Wednesday, January 29, 2020
EyePoint and Ocumension announced a license agreement for development and commercialization of DEXYCU 9% for post-operative inflammation following ocular surgery in Mainland China, Hong Kong, Macau and Taiwan.
read more
LSNE has announced the AEMPS has approved the manufacturing of clinical stage biotechnology based therapeutic products at its aseptic fill finish facility in León, Spain.
read more
BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and lead discussions at several upcoming industry conferences in July, August, and ...
read more
Wednesday, January 13, 2016
Catalent a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products has announced, through its wholly owned subsidiary, Redwood Bioscience, Inc., a research collaboration with Roche...
read more
Wednesday, January 20, 2016
PAREXEL International Corporation, a global biopharmaceutical services organization, announced that the company has entered into a definitive agreement to acquire all outstanding equity securities of Health Advances, LLC, an independent life sciences...
read more
Vetter announced the start of construction on its new site in Saarlouis. During the first construction phase, the company will build a state-of-the-art facility for the commercial production of injectable drugs on the 95-acre industrial site.
read more
Coronado Research has appointed Nick Littlebury as EVP, Regulatory Affairs. Nick is a senior regulatory leader with extensive strategic and operational experience across the pharmaceutical industry's product lifecycle. He has previously led ...
read more
Tuesday, September 23, 2025
RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived exosomes for both human and animal health applications, has announced a collaboration with Lonza, to provide cGMP manufacturing and technical support for ...
read more
The FDA is alerting clinical laboratory staff and health care providers of an increased risk of a false positive result with BD SARS-CoV-2 Reagents for the BD Max System test.
read more
Aptar Pharma acquired worldwide rights to Pharmaxis’ proprietary Orbital™ inhaler, a unique device that can deliver high payload dry powder to the lungs.
read more
Wednesday, December 02, 2015
Tanner Pharma Group has announced the hiring of Jonathan Bracey as Managing Director – UK, effective 1 December, 2015.
read more
Thursday, October 17, 2024
Charles River Laboratories International, Inc. announced the launch of the Retrogenix® Non-Human Protein Library. The non-human protein library helps biopharmaceutical clients assess off-target binding to a non-human proteome to de-risk in vivo ...
read more
Thursday, October 24, 2024
Rentschler Biopharma SE announced the construction of a new state-of-the-art buffer media station at its company headquarters in Laupheim.
read more